Sean E. Harper - Amgen
Last quote by Sean E. Harper
We look forward to working with the FDA to update the label for Repatha, enabling us to more broadly educate physicians and patients of the proven impact of Repatha to reduce cardiovascular events.feedback
Find all of Sean E. Harper’s quotes that have been published in 5 different articles on this page. Sean E. Harper’s quotes are organized by date and topic, making it easy for you to compare, for example, what Sean E. Harper has said both recently, and in the past, on a variety of topics. Some of the topics Sean E. Harper likes to comment on include Americans and migraine. Most recently, Sean E. Harper said, “The efficacy results from this study comparing Evenity to an active control are robust. At the same time, the newly observed cardiovascular safety signal will have to be assessed as part of the overall benefit/risk profile for Evenity.”.
Take our quote verification challenge and find out !
Quotes by Sean E. Harper
May 21 2017
The efficacy results from this study comparing Evenity to an active control are robust. At the same time, the newly observed cardiovascular safety signal will have to be assessed as part of the overall benefit/risk profile for Evenity.feedback
Mar 17 2017
To see a more than 20 percent risk reduction for stroke was really exciting.feedback
Feb 28 2017
Endeavor is the only (relapsed multiple myeloma) study to demonstrate a survival benefit in a head-to-head comparison with a current standard of care regimen.feedback
Jun 08 2016
Migraine is the sixth leading cause of disability worldwide.feedback
Check if the quote you read on social networks is authentic
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided